Physician profile
John D Douthit, SR.
NPI 1053368027
$303.78
in general payments reported to CMS, 2019-2025
8 companies · $20.20 in 2025
The $20.20 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.00 · 2020: $13.56 · 2021: $14.75 · 2022: $97.09 · 2023: $83.77 · 2024: $28.41 · 2025: $20.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $137.32 | 2021-2025 | Vraylar, Qulipta |
| Biohaven Pharmaceutical Holding Company LTD. | $43.84 | 2022 | |
| Astellas Pharma US INC | $34.49 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $28.41 | 2024 | |
| Scilex Pharmaceuticals INC. | $19.43 | 2019 | |
| Currax Pharmaceuticals LLC | $15.19 | 2023 | Contrave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.56 | 2020 | |
| Pfizer INC. | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Douthit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.